SCHEMBL9959233

SCHEMBL9959233

C[C@@]1(c2cccc(Br)c2)Cn2ccnc2C(=O)N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 3/20 0.36
CHRNA1 P02708 1/20 0.34
CHRNG P07510 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
SLC6A2 P23975 1/20 0.34
CHRNB4 P30926 1/20 0.34
SLC6A4 P31645 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNA4 P43681 1/20 0.34
SLC6A3 Q01959 1/20 0.34
CHRND Q07001 1/20 0.34
MEN1 O00255 2/20 0.34
MGAT2 Q10469 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
HSD11B1 P28845 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9958909 1.00 NPSR1 (0.36) NPSR1ALDH1A1KMT2ACHRNA1CHRNG
SCHEMBL9959577 0.86 NPSR1 (0.36) NPSR1ALDH1A1KMT2ACHRNA1CHRNG
SCHEMBL9959296 0.79 BACE1 (0.38) GABRG2GABRB3GABRA5CTSDBACE1
SCHEMBL9959292 0.79 BACE1 (0.38) GABRG2GABRB3GABRA5CTSDBACE1
SCHEMBL12524646 0.79 ALDH1A1 (0.38) ALDH1A1KMT2ACHRNA1CHRNGCHRNB1
SCHEMBL12497658 0.77 ALDH1A1 (0.36) NPSR1ALDH1A1KMT2ACHRNA1CHRNG
SCHEMBL12497659 0.77 ALDH1A1 (0.36) NPSR1ALDH1A1KMT2ACHRNA1CHRNG
SCHEMBL251767 0.75 ALDH1A1 (0.40) ALDH1A1KMT2ACHRNA1CHRNGCHRNB1
SCHEMBL9958645 0.72 BACE1 (0.42) NPSR1ALDH1A1CHRNA1CHRNGCHRNB1
SCHEMBL9958510 0.72 BACE1 (0.42) NPSR1ALDH1A1CHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840507-B2 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE) JANSSEN PHARMACEUTICA, NV (BE) 2017-12-12 US disclosed
EP-2655376-B1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2017-08-23 EP disclosed
EP-2655376-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) Janssen Pharmaceutica NV (BE) 2013-10-30 EP disclosed
US-20130274266-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2013-10-17 US disclosed
WO-2012085038-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274266-A1 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) BACE2, BACE1, PSEN2 NPSR1 1010/4885ALDH1A1 3954/4885KMT2A 1279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.